Targeting Dynamin-Related Protein 1 and Glucose Metabolism Reverses Acquired Resistance to Sorafenib in Liver Cancer
Oncology Research · 2026 · 34 (7) · 1-10
DOI: 10.32604/or.2026.067443 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Jinhui Che und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, Department of General Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, So…. Hauptthemen laut MEDLINE: Sorafenib, Dynamins, Liver Neoplasms, Drug Resistance, Neoplasm. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatobiliary Surgery, Department of General Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.
- Department of Hepatobiliary Surgery, Xuzhou Cancer Hospital, Xuzhou, China.
- Department of Hepatic Surgery and Liver Transplantation Center of the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
- Guangdong Key Laboratory of Liver Disease Research, Key Laboratory of Liver Disease Biotherapy and Translational Medicine of Guangdong Higher Education Institutes, the Third Affiliated Hospital of Sun Yat-sen University…
- Department of Clinical Laboratory, Xuzhou Cancer Hospital, Xuzhou, China.
Zitieren
APA
Che, J., Chen, Z., Zhang, F., Zhu, S., Cao, S., Li, O., Li, R., Zheng, J., & Liu, Y. (2026). Targeting Dynamin-Related Protein 1 and Glucose Metabolism Reverses Acquired Resistance to Sorafenib in Liver Cancer. Oncology Research, 34(7), 1-10. https://doi.org/10.32604/or.2026.067443
Vancouver
Che J, Chen Z, Zhang F, Zhu S, Cao S, Li O, et al. Targeting Dynamin-Related Protein 1 and Glucose Metabolism Reverses Acquired Resistance to Sorafenib in Liver Cancer. Oncology Research. 2026;34(7):1-10. doi:10.32604/or.2026.067443
BibTeX
@article{Che2026,
author = {Che, Jinhui and Chen, Zhiyuan and Zhang, Feng and Zhu, Shuo and Cao, Shengya and Li, Ou and Li, Rong and Zheng, Jun and Liu, Yubin},
title = {Targeting Dynamin-Related Protein 1 and Glucose Metabolism Reverses Acquired Resistance to Sorafenib in Liver Cancer},
journal = {Oncology Research},
year = {2026},
volume = {34},
number = {7},
pages = {1--10},
doi = {10.32604/or.2026.067443}
}
EUVIMED